Argitalpenak (66) Manuel Adolfo Sánchez Martín argitalpenak

2024

  1. RhoA downregulation in the murine intestinal epithelium results in chronic Wnt activation and increased tumorigenesis

    iScience, Vol. 27, Núm. 4

2023

  1. A Potential Effect of Circadian Rhythm in the Delivery/Therapeutic Performance of Paclitaxel–Dendrimer Nanosystems

    Journal of Functional Biomaterials, Vol. 14, Núm. 7

  2. Characterization of mutant versions of the R-RAS2/TC21 GTPase found in tumors

    Oncogene, Vol. 42, Núm. 5, pp. 389-405

  3. METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer

    Molecular cancer, Vol. 22, Núm. 1, pp. 119

  4. N7-methylguanosine methylation of tRNAs regulates survival to stress in cancer

    Oncogene, Vol. 42, Núm. 43, pp. 3169-3181

  5. Prph2 knock-in mice recapitulate human central areolar choroidal dystrophy retinal degeneration and exhibit aberrant synaptic remodeling and microglial activation

    Cell Death and Disease, Vol. 14, Núm. 11

  6. The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors

    Cancer research, Vol. 83, Núm. 2, pp. 239-250

2022

  1. A hotspot mutation targeting the R-RAS2 GTPase acts as a potent oncogenic driver in a wide spectrum of tumors

    Cell Reports, Vol. 38, Núm. 11

  2. A truncating variant of RAD51B associated with primary ovarian insufficiency provides insights into its meiotic and somatic functions

    Cell Death and Differentiation, Vol. 29, Núm. 12, pp. 2347-2361

  3. Bona fide atypical scrapie faithfully reproduced for the first time in a rodent model

    Acta Neuropathologica Communications, Vol. 10, Núm. 1

  4. CRISPR/Cas9‐Directed Gene Trap Constitutes a Selection System for Corrected BCR/ABL Leukemic Cells in CML

    International Journal of Molecular Sciences, Vol. 23, Núm. 12

  5. Myosin Vb as a tumor suppressor gene in intestinal cancer

    Oncogene, Vol. 41, Núm. 49, pp. 5279-5288

  6. New functions of C3G in platelet biology: Contribution to ischemia-induced angiogenesis, tumor metastasis and TPO clearance

    Frontiers in Cell and Developmental Biology, Vol. 10

  7. Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration

    Cancers, Vol. 14, Núm. 16

  8. The Oocyte-Specific Linker Histone H1FOO Is Not Essential for Mouse Oogenesis and Fertility

    Cells, Vol. 11, Núm. 22

2021

  1. CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia

    CRISPR Journal, Vol. 4, Núm. 4, pp. 519-535

  2. Characterization of the platelet phenotype caused by a germline RUNX1 Variant in a CRISPR/Cas9-generated murine model

    Thrombosis and Haemostasis, Vol. 121, Núm. 9, pp. 1193-1205

  3. Cyba-deficient mice display an increase in hematopoietic stem cells and an overproduction of immunoglobulins

    Haematologica, Vol. 106, Núm. 1, pp. 142-153

  4. Future approaches for treating chronic myeloid leukemia: Crispr therapy

    Biology, Vol. 10, Núm. 2, pp. 1-16

  5. Granuloma formation in a cyba-deficient model of chronic granulomatous disease is associated with myeloid hyperplasia and the exhaustion of B-cell lineage

    International Journal of Molecular Sciences, Vol. 22, Núm. 16